Does Rallies show Form 4 insider transactions for PGNY?

Yes. Rallies tracks PGNY insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is PGNY research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PGNY. It does not provide personalized investment advice.

PGNY (Progyny, Inc. Common Stock) Stock Analysis - Insider Trades

Progyny, Inc. Common Stock (PGNY) is a publicly traded Healthcare sector company. As of May 21, 2026, PGNY trades at $25.61 with a market cap of $1.88B and a P/E ratio of 37.40. PGNY moved +4.35% today. Year to date, PGNY is -3.83%; over the trailing twelve months it is +17.24%. Its 52-week range spans $13.39 to $28.75. Analyst consensus is strong buy with an average price target of $27.75. Rallies surfaces PGNY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading PGNY stock inside the company?

Recent PGNY insider activity includes Swartz Allison sold 599, Swartz Allison sold 500, Swartz Allison sold 4.16K, Swartz Allison sold 2.20K, and Livingston Mark S. sold 459. Rallies tracks insider transaction dates, shares, prices, and estimated values.

PGNY Key Metrics

Key financial metrics for PGNY
Metric	Value
Price	$25.61
Market Cap	$1.88B
P/E Ratio	37.40
EPS	$0.68
Dividend Yield	0.00%
52-Week High	$28.75
52-Week Low	$13.39
Volume	1.78M
Avg Volume	0
Revenue (TTM)	$1.29B
Net Income	$58.52M
Gross Margin	23.63%

Recent PGNY Insider Trades

Swartz Allison sold 599 (~$10.51K) on Mar 4, 2026.
Swartz Allison sold 500 (~$8.70K) on Mar 3, 2026.
Swartz Allison sold 4.16K (~$72.33K) on Mar 3, 2026.
Swartz Allison sold 2.20K (~$37.98K) on Mar 2, 2026.
Livingston Mark S. sold 459 (~$11.70K) on Dec 11, 2025.

Latest PGNY News

Barclays Raises Progyny Price Target to $27 After Q1 EPS Beat — May 15, 2026
Progyny Q1 Fertility Benefits Revenue Up 24% with $75M Buyback — May 8, 2026
Progyny Delivers Record Q1 Revenue of $328.5M, Gross Margin Hits 25.3% — May 7, 2026
Progyny sees Q1 revenue of $326.5M, EPS $0.26 with 12-month $27.55 target — May 6, 2026
Progyny Launches Fully Insured Fertility Plan with Fixed PEPM for Small Employers — Apr 16, 2026

PGNY Analyst Consensus

9 analysts cover PGNY: 0 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $27.75.

Common questions about PGNY

Who is trading PGNY stock inside the company?: Recent PGNY insider activity includes Swartz Allison sold 599, Swartz Allison sold 500, Swartz Allison sold 4.16K, Swartz Allison sold 2.20K, and Livingston Mark S. sold 459. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for PGNY?: Yes. Rallies tracks PGNY insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PGNY research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PGNY. It does not provide personalized investment advice.